{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:15:44Z","timestamp":1782234944317,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ejmech.2018.05.034","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T12:36:01Z","timestamp":1526992561000},"page":"13-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"special_numbering":"C","title":["Synthesis, characterization and biological evaluation of tertiary sulfonamide derivatives of pyridyl-indole based heteroaryl chalcone as potential carbonic anhydrase IX inhibitors and anticancer agents"],"prefix":"10.1016","volume":"155","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8893-0450","authenticated-orcid":false,"given":"Mudasir Nabi","family":"Peerzada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8566-0248","authenticated-orcid":false,"given":"Parvez","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3663-4940","authenticated-orcid":false,"given":"Md Imtaiyaz","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Azam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.05.034_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2018.05.034_bib2","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nrc2870","article-title":"Envisioning the future of early anticancer drug development","volume":"10","author":"Yap","year":"2010","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.ejmech.2018.05.034_bib3","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1186\/1471-2407-14-400","article-title":"Carbonic anhydrase 9 is associated with chemosensitivity and prognosis in breast cancer patients treated with taxane and anthracycline","volume":"14","author":"Aomatsu","year":"2014","journal-title":"BMC Canc."},{"key":"10.1016\/j.ejmech.2018.05.034_bib4","first-page":"1","article-title":"CA IX stratification based on cancer treatment: a patent evaluation of US2016\/0002350","author":"Supuran","year":"2016","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2018.05.034_bib5","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ijbiomac.2017.08.082","article-title":"Biological evaluation of p-toluene sulphonylhydrazone as carbonic anhydrase IX inhibitors: an approach to fight hypoxia-induced tumors","volume":"106","author":"Queen","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2018.05.034_bib6","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.bmc.2012.04.044","article-title":"Structure, function and applications of carbonic anhydrase isozymes","volume":"21","author":"Imtaiyaz Hassan","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.034_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/1568009023334060","article-title":"Sulfonamides and sulfonylated derivatives as anticancer agents","volume":"2","author":"Casini","year":"2002","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ejmech.2018.05.034_bib8","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2018.05.034_bib9","article-title":"Understanding the role and mechanism of carbonic anhydrase V in obesity and its therapeutic implications","volume":"18","author":"Queen","year":"2017","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.ejmech.2018.05.034_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejmech.2013.10.081","volume":"71","author":"Zolnowska","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.034_bib11","doi-asserted-by":"crossref","first-page":"6015","DOI":"10.1039\/c3cc40858b","article-title":"New superacid synthesized (fluorinated) tertiary benzenesulfonamides acting as selective hCA IX inhibitors: toward a new mode of carbonic anhydrase inhibition by sulfonamides","volume":"49","author":"Metayer","year":"2013","journal-title":"Chem. Commun. (J. Chem. Soc. Sect. D)"},{"key":"10.1016\/j.ejmech.2018.05.034_bib12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.034_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jmgm.2016.01.006","article-title":"Design and synthesis of a novel class of carbonic anhydrase-IX inhibitor 1-(3-(phenyl\/4-fluorophenyl)-7-imino-3H-[1,2,3]triazolo[4,5d]pyrimidin 6(7H)yl)urea","volume":"64","author":"Kumari","year":"2016","journal-title":"J.\u00a0Mol. Graph. Model."},{"key":"10.1016\/j.ejmech.2018.05.034_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2016.05.025","article-title":"Indoles - a promising scaffold for drug development","volume":"91","author":"Sravanthi","year":"2016","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2018.05.034_bib15","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1021\/jm500002k","article-title":"Design, synthesis, and biological evaluation of novel pyridine-bridged analogues of combretastatin-A4 as anticancer agents","volume":"57","author":"Zheng","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.034_bib16","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ejmech.2013.09.027","article-title":"Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII","volume":"69","author":"Slawinski","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.034_bib17","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ejmech.2017.12.049","article-title":"Design, synthesis and biological evaluation of novel pyridine-thiazolidinone derivatives as anticancer agents: targeting human carbonic anhydrase IX","volume":"144","author":"Ansari","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.034_bib18","doi-asserted-by":"crossref","first-page":"7762","DOI":"10.1021\/acs.chemrev.7b00020","article-title":"Chalcone: a privileged structure in medicinal chemistry","volume":"117","author":"Zhuang","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2018.05.034_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/14756366.2016.1221825","article-title":"Synthesis and bioactivities of halogen bearing phenolic chalcones and their corresponding bis Mannich bases","volume":"31","author":"Yamali","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.034_bib20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/092986712803414132","article-title":"Exploring pharmacological significance of chalcone scaffold: a review","volume":"19","author":"Sahu","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.034_bib21","doi-asserted-by":"crossref","first-page":"7909","DOI":"10.1016\/j.bmc.2009.10.022","article-title":"Synthesis and biological evaluation of 3',4',5'-trimethoxychalcone analogues as inhibitors of nitric oxide production and tumor cell proliferation","volume":"17","author":"Rao","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.034_bib22","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.drudis.2013.01.008","article-title":"Shifting from the single to the multitarget paradigm in drug discovery","volume":"18","author":"Medina-Franco","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2018.05.034_bib23","doi-asserted-by":"crossref","first-page":"8743","DOI":"10.1002\/anie.201004437","article-title":"Combining independent drug classes into superior, synergistically acting hybrid molecules","volume":"49","author":"Muller-Schiffmann","year":"2010","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2018.05.034_bib24","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1021\/acs.jpcb.7b03191","article-title":"Mechanism of the piperidine-catalyzed Knoevenagel condensation reaction in methanol: the role of iminium and enolate ions","volume":"121","author":"Dalessandro","year":"2017","journal-title":"J.\u00a0Phys. Chem. B"},{"key":"10.1016\/j.ejmech.2018.05.034_bib25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2018.05.034_bib26","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejmech.2017.07.073","article-title":"Novel 4\/3-((4-oxo-5-(2-oxoindolin-3-ylidene)thiazolidin-2-ylidene)amino) benzenesulfonamides: synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular modelling studies","volume":"139","author":"Eldehna","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.034_bib27","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1517\/14728222.2016.1086339","article-title":"Carbonic anhydrase IX inhibition is an effective strategy for osteosarcoma treatment","volume":"19","author":"Perut","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejmech.2018.05.034_bib28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12885-016-2267-4","article-title":"Apoptosis-induced ectodomain shedding of hypoxia-regulated carbonic anhydrase IX from tumor cells: a double-edged response to chemotherapy","volume":"16","author":"Vidlickova","year":"2016","journal-title":"BMC Canc."},{"key":"10.1016\/j.ejmech.2018.05.034_bib29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ejmech.2015.04.033","article-title":"Synthesis, carbonic anhydrase inhibition and cytotoxic activity of novel chromone-based sulfonamide derivatives","volume":"96","author":"Awadallah","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.034_bib30","article-title":"Receptor chemoprint derived pharmacophore model for development of CA IX inhibitors","volume":"003","author":"Amresh P","year":"2013","journal-title":"J.\u00a0Carcinog. Mutagen."},{"key":"10.1016\/j.ejmech.2018.05.034_bib31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijbiomac.2017.07.010","article-title":"Estimation of thermodynamic stability of human carbonic anhydrase IX from urea-induced denaturation and MD simulation studies","volume":"105","author":"Idrees","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2018.05.034_bib32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12010-014-0850-1","article-title":"Luminol-based chemiluminescent signals: clinical and non-clinical application and future uses","volume":"173","author":"Khan","year":"2014","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.ejmech.2018.05.034_bib33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11030-016-9714-7","article-title":"Design, synthesis, in silico and biological evaluation of novel 2-(4-(4-substituted piperazin-1-yl)benzylidene)hydrazine carboxamides","volume":"21","author":"Kumari","year":"2017","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2018.05.034_bib34","doi-asserted-by":"crossref","first-page":"9470","DOI":"10.1038\/s41598-017-09941-4","article-title":"Elucidation of dietary polyphenolics as potential inhibitor of microtubule affinity regulating kinase 4: in silico and in\u00a0vitro studies","volume":"7","author":"Khan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2018.05.034_bib35","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/cbdd.12898","article-title":"Design, synthesis, and biological evaluation of pyrimidine derivatives as potential inhibitors of human calcium\/calmodulin-dependent protein kinase IV","volume":"89","author":"Jameel","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"issue":"50","key":"10.1016\/j.ejmech.2018.05.034_bib36","doi-asserted-by":"crossref","DOI":"10.3791\/2597","article-title":"Modified annexin V\/propidium iodide apoptosis assay for accurate assessment of cell death","author":"Rieger","year":"2011","journal-title":"JoVE"},{"key":"10.1016\/j.ejmech.2018.05.034_bib37","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1021\/ja01164a032","article-title":"The quenching of fluorescence. Deviations from the Stern-Volmer law","volume":"72","author":"Boaz","year":"1950","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.05.034_bib38","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2174\/1570180814666161214114322","article-title":"Pharmacokinetic evaluation of callistemon viminalis derived natural compounds as targeted inhibitors against \u03b4-opioid receptor and farnesyl transferase","volume":"14","author":"Ahmad","year":"2017","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.ejmech.2018.05.034_bib39","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1073\/pnas.0908301106","article-title":"Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX","volume":"106","author":"Alterio","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2018.05.034_bib40","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J.\u00a0Comput. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418304471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418304471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T16:17:31Z","timestamp":1563034651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418304471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":40,"alternative-id":["S0223523418304471"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.05.034","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, characterization and biological evaluation of tertiary sulfonamide derivatives of pyridyl-indole based heteroaryl chalcone as potential carbonic anhydrase IX inhibitors and anticancer agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.05.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}